ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 105 filers reported holding ALBIREO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $221,756 | -2.3% | 7,434 | -23.7% | 0.00% | – |
| Q4 2021 | $227,000 | -24.3% | 9,743 | +1.5% | 0.00% | – |
| Q3 2021 | $300,000 | -15.7% | 9,601 | -5.3% | 0.00% | – |
| Q2 2021 | $356,000 | -2.7% | 10,133 | -2.3% | 0.00% | – |
| Q1 2021 | $366,000 | -6.6% | 10,373 | -0.7% | 0.00% | – |
| Q4 2020 | $392,000 | +45.7% | 10,451 | +29.5% | 0.00% | – |
| Q3 2020 | $269,000 | +18.5% | 8,072 | -3.1% | 0.00% | – |
| Q2 2020 | $227,000 | -1.3% | 8,329 | +16.9% | 0.00% | – |
| Q2 2019 | $230,000 | -14.5% | 7,125 | -5.9% | 0.00% | – |
| Q2 2018 | $269,000 | +2345.5% | 7,572 | +2057.3% | 0.00% | – |
| Q1 2018 | $11,000 | +22.2% | 351 | -0.3% | 0.00% | – |
| Q4 2017 | $9,000 | +28.6% | 352 | +1.1% | 0.00% | – |
| Q3 2017 | $7,000 | +600.0% | 348 | +582.4% | 0.00% | – |
| Q2 2017 | $1,000 | – | 51 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 1,704,330 | $60,504,000 | 1.59% |
| Birchview Capital, LP | 38,000 | $1,349,000 | 0.92% |
| Virtus ETF Advisers LLC | 24,688 | $876,000 | 0.77% |
| BVF INC/IL | 220,000 | $7,810,000 | 0.76% |
| SECTORAL ASSET MANAGEMENT INC | 172,803 | $6,135,000 | 0.69% |
| Chicago Capital, LLC | 134,748 | $4,784,000 | 0.39% |
| Artal Group S.A. | 500,000 | $17,750,000 | 0.38% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $25,432,000 | 0.33% |
| Eversept Partners, LP | 18,029 | $640,030 | 0.29% |
| HEARTLAND ADVISORS INC | 125,000 | $4,438,000 | 0.29% |